(Q44058235)

English

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer (English)

1 reference

Europe PubMed Central

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Peter D Siersema

3

object named as

Siersema PD

1 reference

Europe PubMed Central

29 November 2017

author name string

Polee MB

1

1 reference

Europe PubMed Central

29 November 2017

Verweij J

2

1 reference

Europe PubMed Central

29 November 2017

Tilanus HW

4

1 reference

Europe PubMed Central

29 November 2017

Splinter TA

5

1 reference

Europe PubMed Central

29 November 2017

Stoter G

6

1 reference

Europe PubMed Central

29 November 2017

Van der Gaast A

7

1 reference

Europe PubMed Central

29 November 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

29 November 2017

European Journal of Cancer

1 reference

Europe PubMed Central

29 November 2017

38

1 reference

Europe PubMed Central

29 November 2017

11

1 reference

Europe PubMed Central

29 November 2017

1495-1500

1 reference

Europe PubMed Central

29 November 2017

Surgical therapy of oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A 15-year review of esophagectomy for carcinoma of the esophagus and cardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged chemotherapy for localised squamous carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of weekly paclitaxel in advanced lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel administered by 1-hour infusion. Preliminary results of a phase I/II trial comparing two schedules.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-paclitaxel weekly schedule in advanced solid tumors: a phase I study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing Presentation and Management of Neutropenic Enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutropenic enterocolitis and Clostridium septicum infection in patients with agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(02)00081-3

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44058235&oldid=2106111262"